Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine

Ann Hematol. 2018 Oct;97(10):2001-2003. doi: 10.1007/s00277-018-3351-4. Epub 2018 May 4.

Greta Scapinello¹, Marco Pizzi², Stefania Vio³, Mitja Nabergoj^{1

4}, Andrea Visentin¹, Annalisa Martines⁵, Laura Bonaldi⁵, Livio Trentin¹, Gianpietro Semenzato^{1

6}, Francesco Piazza^{7

8}

¹ Hematology Unit, Department of Medicine - DIMED, University of Padova, Via Giustiniani, 2, Padova, Italy.
² Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy.
³ Radiology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy.
⁴ Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
⁵ Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy.
⁶ Laboratory of Normal and Malignant Hematopoiesis, Venetian Institute of Molecular Medicine, Via Orus 2, Padova, Italy.
⁷ Hematology Unit, Department of Medicine - DIMED, University of Padova, Via Giustiniani, 2, Padova, Italy. francesco.piazza@unipd.it.
⁸ Laboratory of Normal and Malignant Hematopoiesis, Venetian Institute of Molecular Medicine, Via Orus 2, Padova, Italy. francesco.piazza@unipd.it.

No abstract available

Publication types